Espirometría

Sanchís Aldás, 1997 Ferguson, 2000, Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program, Chest, 117, 1146, 10.1378/chest.117.4.1146 Neas, 1998, Pulmonary function levels as predictors of mortality in a national sample of US adults, Am J Epidemiol, 147, 1011, 10.1093/oxfordjournals.aje.a009394 Schunemann, 2000, Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study, Chest, 118, 656, 10.1378/chest.118.3.656 Chyou, 1996, Pulmonary function measures as predictors and correlates of cognitive functioning in later life, Am J Epidemiol, 143, 750, 10.1093/oxfordjournals.aje.a008812 Quanjer, 1993, Lung volumes and forced ventilatory flows, Eur Respir J, 6, 5, 10.1183/09041950.005s1693 1995, Standardization of spirometry, 1994 Update, Am J Respir Crit Care Med, 152, 1107, 10.1164/ajrccm.152.3.7663792 Crapo, 1994, Pulmonary-function testing, N Engl J Med, 331, 25, 10.1056/NEJM199407073310107 Miller, 2005, Standardization of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 2012, Arch Bronconeumol, 48, 2 1993, Statement on respiratory mechanics in infants: Physiologic evaluation in health and disease, Eur Respir J, 6, 279 Kanengiser, 1994, Forced espiratory manoeuvres in children aged 3-5 years, Pediatr Pulmonol, 18, 144, 10.1002/ppul.1950180305 Cooper, 2011, An update on contraindications for lung function testing, Thorax, 66, 714, 10.1136/thx.2010.139881 1996, Spirometry. Contraindications for use of spirometry. 1996 Update, Respir Care, 41, 629 Butler, 1995, Diving and hyperbaric ophthalmology, Surv Ophthalmol, 39, 347, 10.1016/S0039-6257(05)80091-8 Jing, 2009, Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis, Chest, 135, 991, 10.1378/chest.08-0723 Aurora, 2004, Quality control for spirometry in preschool-children with and without lung disease, Am J Respir Crit Care Med, 169, 1152, 10.1164/rccm.200310-1453OC O’Donnell, 1997, Qualitative aspects of exertional breathlessness in chronic airflow limitation: Pathophysiological mechanisms, Am J Respir Crit Care Med, 155, 109, 10.1164/ajrccm.155.1.9001298 Miller, 2005, General considerations for lung function testing, Eur Respir J, 26, 153, 10.1183/09031936.05.00034505 Van Schalkwyk, 2004, South African Thoracic Society Standards of Spirometry Committee. Guideline for office spirometry in adults, 2004, S Afr Med J, 94, 576 Torres Martí, 1998, 1 Jensen, 2007, Sources of long-term variability in measurements of lung function: Implications for interpretation and clinical trial design, Chest, 132, 396, 10.1378/chest.06-1999 Enright, 2004, Repeatability of spirometry in 18,000 adult patients, Am J Respir Crit Care Med, 169, 235, 10.1164/rccm.200204-347OC Steenbruggen, 2011, Harmonising spirometry education with HERMES: Training a new generation of qualified spirometry practitioners across Europe, Eur Respir J, 37, 479, 10.1183/09031936.00187810 Parker, 1996, Arm span-height relationships in patients referred for spirometry, Am J Respir Crit Care Med, 154, 533, 10.1164/ajrccm.154.2.8756834 Verrall, 1989, Use of noseclips in pulmonary function test, J Occup Med, 31, 29 Chavesse, 2003, To clip or not to clip? Nose clips for spirometry, Eur Respir J, 21, 876, 10.1183/09031936.03.00048303 D’Angelo, 1993, Dependence of maximal flow-volume curves on time course preceding inspiration, J Appl Physiol, 75, 1155, 10.1152/jappl.1993.75.3.1155 Beydon, 2007, An official American Thoracic Society/European Respiratory Society statement: Pulmonary function testing in preschool children, Am J Respir Crit Care Med, 175, 1304, 10.1164/rccm.200605-642ST Arets, 2001, Forced expiratory manoeuvres in children: Do they meet ATS and ERS criteria for spirometry?, Eur Respir J, 18, 655, 10.1183/09031936.01.00204301 Pérez-Padilla, 2008, Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease, Respir Care, 53, 1019 National Health and Nutrition Examination Survey (NHANES). Respiratory Health. Spirometry procedures manual. Centers for Disease Control and Prevention, 2008 [consultado 10 Feb 2013]. Disponible en: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/spirometry.pdf Enright, 2010, Quality of spirometry performed by 13.599 participants in the World Trade Center Worker and Volunteer Medical Screening Program, Respir Care, 55, 303 Pellegrino, 2005, Interpretative strategies for lung function tests, Eur Respir J, 26, 948, 10.1183/09031936.05.00035205 Casan, 1983, Spirometric response to a bronchodilator. Reference values for healthy children and adolescents, Bull Eur Physiopathol Respir, 19, 567 Castellsaguer, 1998, Prediction equations for forced spirometry from European origin population, Respir Med, 92, 401, 10.1016/S0954-6111(98)90282-7 García-Río, 2004, Spirometric reference equations for European females and males aged 65-85 yrs, Eur Respir J, 24, 397, 10.1183/09031936.04.00088403 Quanjer, 2012, Multi-ethnic reference values for spirometry for the 3-95 year age range: The global lung function 2012 equations, Eur Respir J, 40, 1324, 10.1183/09031936.00080312 Vaz Fragoso, 2011, Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons, Respir Care, 56, 1771, 10.4187/respcare.01192 Vaz Fragoso, 2012, Respiratory impairment and the aging lung: A novel paradigm for assessing pulmonary function, J Gerontol A Biol Sci Med Sci, 67, 264, 10.1093/gerona/glr198 Mohanka, 2012, A survey of practices of pulmonary function interpretation in laboratories in Northeast Ohio, Chest, 141, 1040, 10.1378/chest.11-1141 Culver, 2012, How should the lower limit of the normal range be defined?, Respir Care, 57, 136, 10.4187/respcare.01427 Global Initiative for Chronic Lung Disease. GOLD spirometry guide–2010 update [consultado 10 Feb 2013]. Disponible en: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf Schermer, 2008, Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care, Eur Respir J, 32, 945, 10.1183/09031936.00170307 Vollmer, 2009, Comparison of spirometry criteria for the diagnosis of COPD: Results from the BOLD study, Eur Respir J, 34, 588, 10.1183/09031936.00164608 Flenley, 1988, Chronic obstructive pulmonary disease, Dis Mon, 34, 537, 10.1016/0011-5029(88)90015-6 Bon, 2008, A unique spirometric phenotype in COPD, Am J Respir Crit Care Med, 178, 431, 10.1164/ajrccm.178.4.431a Kanner, 1983, Predictors of survival in subjects with chronic airflow limitation, Am J Med, 74, 249, 10.1016/0002-9343(83)90623-X Anthonisen, 1986, Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, 133, 14, 10.1164/arrd.1986.133.1.14 Aaron, 1999, How accurate is spirometry at predicting restrictive pulmonary impairment?, Chest, 115, 869, 10.1378/chest.115.3.869 Glady, 2003, A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory, Chest, 123, 1939, 10.1378/chest.123.6.1939 Hong, 2008, Poor interpretation of pulmonary function tests in patients with concomitant decreases in FEV1 and FVC, Respirology, 13, 569, 10.1111/j.1440-1843.2008.01274.x Aggarwal, 2007, The new ATS/ERS guidelines for assessing the spirometric severity of restrictive lung disease differ from previous standards, Respirology, 12, 759, 10.1111/j.1440-1843.2007.01117.x Burrows, 1986, Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers, Am Rev Respir Dis, 133, 974 Spencer, 1992, A superior method of assessing the reproducibility of pulmonary function measurements, Am Rev Respir Dis, 145, A253 Miller, 2000, Peak flow meter resistance decreases peak expiratory flow in subjects with COPD, J Appl Physiol, 89, 283, 10.1152/jappl.2000.89.1.283 2009, Pulmonary Function Laboratory Management and Procedure Manual, Bronchial Reversibility Test Brand, 1992, The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group, Thorax, 47, 429, 10.1136/thx.47.6.429 Calverley, 2003, Bronchodilator reversibility testing in chronic obstructive pulmonary disease, Thorax, 58, 659, 10.1136/thorax.58.8.659 Guyatt, 1988, Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation, Arch Intern Med, 148, 1949, 10.1001/archinte.1988.00380090043011 Hanania, 2011, Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial, Respir Res, 12, 6, 10.1186/1465-9921-12-6 Mendella, 1982, Steroid response in stable chronic obstructive pulmonary disease, Ann Intern Med, 96, 17, 10.7326/0003-4819-96-1-17 Enright, 1994, Physiologic measures: Pulmonary function tests. Asthma outcome, Am J Respir Crit Care Med, 149, S9, 10.1164/ajrccm/149.2_Pt_2.S9 National Asthma Education Program. Expert panel report-guidelines for diagnosis and management of asthma. NIH. 1991. Publication 91-3042A. Real Decreto 1971/1999 de 23 de diciembre, de reconocimiento, declaración y calificación del grado de minusvalía. Capítulo 4. 1999. Zibrak, 1990, Indications for pulmonary function testing, Ann Intern Med, 112, 763, 10.7326/0003-4819-112-10-763 Lim, 1989, The effects of deep inhalation on maximal expiratory flow during intensive treatment of spontaneous asthmatic episodes, Am Rev Respir Dis, 140, 340, 10.1164/ajrccm/140.2.340 Celli, 2011, Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD, Respir Med, 105, 1176, 10.1016/j.rmed.2011.02.020 Gross, 1988, Ipratropium bromide, N Engl J Med, 319, 486, 10.1056/NEJM198808253190806 Burge, 1980, Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol, Br J Dis Chest, 74, 259, 10.1016/0007-0971(80)90052-2 Ruffin, 1977, A comparison of the bronchodilator activity of Sch 1000 and salbutamol, J Allergy Clin Immunol, 59, 136, 10.1016/0091-6749(77)90215-9 Chapman, 1991, Anticholinergic bronchodilators for adult obstructive airways disease, Am J Med, 91, 13S, 10.1016/0002-9343(91)90256-W 1994, In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial, Chest, 105, 1411, 10.1378/chest.105.5.1411 Gross, 1998, Dey Combination Solution Study Group, Respiration, 65, 354, 10.1159/000029295 Smith, 1992, The utility of spirometry in the diagnosis of reversible airways obstruction, Chest, 101, 1577, 10.1378/chest.101.6.1577 Eiser, 2001, Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?, Respir Med, 95, 476, 10.1053/rmed.2001.1071 Rodriguez-Carballeira, 1999, Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease, Pulm Pharmacol Ther, 12, 43 Criteria for the assessment of reversibility in airways obstruction. Report of the Committee on Emphysema American College of Chest, Physicians. Chest. 1974; 65:552–3. Eliasson, 1985, Influence of clinical diagnosis, spirometric, and anthropometric variables, Am Rev Respir Dis, 132, 858 Tweeddale, 1987, Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects, Thorax, 42, 487, 10.1136/thx.42.7.487 Sourk, 1983, Bronchodilator testing: Confidence intervals derived from placebo inhalations, Am Rev Respir Dis, 128, 153, 10.1164/arrd.1983.128.1.153 Kainu, 2008, FEV1 response to bronchodilation in an adult urban population, Chest, 134, 387, 10.1378/chest.07-2207 Tashkin, 2008, Bronchodilator responsiveness in patients with COPD, Eur Respir J, 31, 742, 10.1183/09031936.00129607 Han, 2010, Prevalence and clinical correlates of broncho-reversibility in severe emphysema, Eur Respir J, 35, 1048, 10.1183/09031936.00052509 Hughes, 1982, Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema, Thorax, 37, 667, 10.1136/thx.37.9.667 Martinez, 1997, Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function, Am J Respir Crit Care Med, 155, 1984, 10.1164/ajrccm.155.6.9196106 O’Donnell, 1998, Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 158, 1557, 10.1164/ajrccm.158.5.9804004 O’Donnell, 1999, Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 160, 542, 10.1164/ajrccm.160.2.9901038 2009, Guía Española para el Manejo del Asma (GEMA), Arch Bronconeumol, 45, 2 Dekker, 1992, Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction, Thorax, 47, 162, 10.1136/thx.47.3.162 Pellegrino, 1998, Assessing the reversibility of airway obstruction, Chest, 114, 1607, 10.1378/chest.114.6.1607 O’Donnell, 2000, Assessment of bronchodilator efficacy in symptomatic COPD: Is spirometry useful?, Chest, 117, 42S, 10.1378/chest.117.2_suppl.42S Boggs, 1982, The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics, Ann Allergy, 48, 139 Berger, 1998, Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction, Chest, 93, 541, 10.1378/chest.93.3.541 Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2011 [consultado 10 Feb 2013]. Disponible en: http://www.ginasthma.org McCormack, 2008, Making the diagnosis of asthma, Respir Care, 53, 583 National Clinical Guideline Centre. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010 [consultado 10 Feb 2013]. Disponible en: http://guidance.nice.org.uk/CG101/Guidance/pdf/English Soler-Cataluña, 2012, Documento de consenso sobre el fenotipo mixto EPOC/asma, Arch Bronconeumol, 48, 331, 10.1016/j.arbres.2011.12.009 Tashkin, 2003, Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses, Chest, 123, 1441, 10.1378/chest.123.5.1441 Vestbo, 2011, Changes in forced expiratory volume in 1 second overtime in COPD, N Engl J Med, 365, 1184, 10.1056/NEJMoa1105482 Boushey, 2005, Spirometry for chronic obstructive pulmonary disease case finding in primary care?, Am J Respir Crit Care Med, 172, 1481, 10.1164/rccm.2509009 Hueto, 2006, La espirometría en atención primaria en Navarra, Arch Bronconeumol, 42, 326, 10.1157/13090582 Johns, 2006, National survey of spirometer ownership and usage in general practice in Australia, Respirology, 11, 292, 10.1111/j.1440-1843.2006.00851.x White, 2005, Should we use spirometry in the early detection of COPD?, Eur Respir J, 26, 558, 10.1183/09031936.05.00061705 Enright, 2006, Does screening for COPD by primary care physicians have the potential to cause more harm than good?, Chest, 129, 833, 10.1378/chest.129.4.833 Han, 2007, Spirometry utilization for COPD: How do we measure up?, Chest, 132, 403, 10.1378/chest.06-2846 Liistro, 2006, Technical and functional assessment of 10 office spirometers: A multicenter comparative study, Chest, 130, 657, 10.1378/chest.130.3.657 Derom, 2008, Primary care spirometry, Eur Respir J, 31, 197, 10.1183/09031936.00066607 Petty, 2001, Simple office spirometry, Clin Chest Med, 22, 845, 10.1016/S0272-5231(05)70070-8 Swanney, 2000, FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction, Am J Respir Crit Care Med, 162, 917, 10.1164/ajrccm.162.3.9907115 Eaton, 1999, Spirometry in primary care practice: The importance of quality assurance and the impact of spirometry workshops, Chest, 116, 416, 10.1378/chest.116.2.416 Levy, 2009, Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations, Prim Care Respir J, 18, 130, 10.4104/pcrj.2009.00054 Wanger, 1997, Office spirometry: Equipment selection and training of staff in the private practice setting, J Asthma, 34, 93, 10.3109/02770909709075653 Gardner, 1992, Evaluation of accuracy and reproducibility of peak flow meters at 1.400 meters, Chest, 101, 948, 10.1378/chest.101.4.948 Fritha, 2011, Simplified COPD screening: Validation of the PiKo-6® in primary care, Prim Care Respir J, 20, 190, 10.4104/pcrj.2011.00040 Dolin, 2006, HL7 Clinical Document Architecture, Release 2, J Am Med Inform Assoc, 13, 30, 10.1197/jamia.M1888 Salas, 2011, Requerimientos técnicos de los espirómetros en la estrategia para garantizar el acceso a una espirometría de calidad, Arch Bronconeumol, 47, 466, 10.1016/j.arbres.2011.06.005 Lum, 1999, Telemedical education: Teaching spirometry on the internet, Am J Physiol, 276, S55 Bellia, 2000, Quality control of spirometry in the elderly. The SARA study. Salute Respiration nell’ Anziano. Respiratory Health in the Elderly, Am J Respir Crit Care Med, 161, 1094, 10.1164/ajrccm.161.4.9810093 Bonavia, 2009, The Italian «Alliance» study, Respir Med, 103, 866 Masa, 2011, On-line spirometry. Validity of spirometry performed online, Eur Respir J, 37, 911, 10.1183/09031936.00011510 Burgos, 2012, Telemedicine enhances quality of forced spirometry in primary care, Eur Respir J, 39, 1313, 10.1183/09031936.00168010